Table 3.
Model 1 | B | SE | HR | 95% CI | p | |
---|---|---|---|---|---|---|
Inferior | Superior | |||||
Male gender | .62 | .22 | 1.86 | 1.20 | 2.88 | 0.005 |
Age | .08 | .01 | 1.09 | 1.06 | 1.12 | <0.001 |
Lipid-lowering drugs | -.57 | .24 | .56 | .35 | .90 | 0.017 |
Triglycerides tertiles | ||||||
- I tertile | 1 | - | - | 0.054 | ||
- II tertile | .31 | .26 | 1.37 | .82 | 2.30 | 0.233 |
- III tertile | .63 | .26 | 1.87 | 1.12 | 3.13 | 0.016 |
Antidiabetic treatment | ||||||
- Diet | 1 | - | - | 0.011 | ||
- Biguanides | -.76 | .37 | .47 | .22 | .96 | 0.040 |
- Sulfonylureas | -.74 | .64 | .48 | .14 | 1.67 | 0.247 |
- Biguanides + Sulfonylureas | -.86 | .35 | .42 | .21 | .83 | 0.013 |
- Insulin | .11 | .35 | 1.11 | .56 | 2.20 | 0.756 |
- Insulin + OHA | -.21 | .37 | .81 | .39 | 1.66 | 0.568 |
In the Cox model: age, gender; tertiles of Body Mass Index; Fasting Blood Glucose, HbA1c, systolic blood pressure, serum LDL-C, HDL-C, and triglycerides mean values; antihypertensive drugs, lipid-lowering drugs, and antidiabetic treatment.